Search – Page 168 – Indianapolis Business Journal

Home » Search

Articles

Lilly wins ban of generic Strattera pending appeal

September 1, 2010

The U.S. Court of Appeals for the Federal Circuit in Washington on Tuesday granted Lilly’s request to prevent sales until the court rules on a judge’s decision invalidating a patent on the medicine.

CFO of the Year: Past recipients

August 31, 2010

Previous Top Honorees are not eligible for nomination. Remaining honorees are eligible. 2022 Not-For-Profit Mark Kern, Chief Financial Officer, Firefly Children and Family Alliance – Top Honoree Michael E. Johnson, Chief Financial Officer, CICOA Aging & In-Home, Solutions Inc. Jenny Skehan, Chief Financial Officer, Girl Scouts of Central Indiana Government Schools Brian Tomamichel, Assistant Superintendent […]

After health reform, Lilly looking for more

August 31, 2010

The health reform debate may have ended in Congress, but Eli Lilly and Co. remains active, sponsoring a talk about the positives of the
bill—and calling for further government efforts to help pharmaceutical research and development.

Lilly wins further delay in sales of Strattera copies

August 27, 2010

Strattera generated U.S. sales of $445.6 million last year, and each day that Lilly can fend off generic competition would
translate into an average $1.22 million in sales.

Indiana universities nearly double research spending

August 26, 2010

In the last 10 years, Indiana’s major research universities—Indiana and Purdue—have nearly doubled their
science-based research budgets, to a total of $895 million. Yet Indiana’s public universities still run in the middle
of the pack nationally.

Funeral company in 129th year keeps fresh perspective

August 26, 2010

Flanner and Buchanan Funeral Centers sometimes stretches the definition of “funeral” to stay relevant after nearly
130 years. The family-owned business began downtown and has grown northward along with the city’s population. Today,
it has 14 funeral centers and conducted 2,200 funerals last year.

Diabetes research pioneer Kirtley dies at 96

August 25, 2010

Diabetics who control their disease with pills instead of frequent insulin injections can thank Dr. William R. Kirtley, a
groundbreaking Eli Lilly researcher.

A half-century later, Indiana Landmarks returns to roots

August 25, 2010

Bankrolled by yet another multimillionaire, the historic preservation group is preparing to move into a new headquarters
in Old Centrum, a former church now undergoing a big renovation.

People

August 24, 2010

Dr. Daniel Kraft has joined Riley Hospital for Children to oversee Riley’s new sports medicine program
for young athletes. Kraft most recently served as the founder and director of the Youth Sports Medicine Institute at Methodist
Sports Medicine—The Orthopedic Specialists. Both Riley and Methodist are owned by Indianapolis-based Clarian Health.

Dr. Jennifer Eikenberry and Dr. Amy M. Waddell have joined the Eugene and Marilyn Glick
Eye Institute at the Indiana University School of Medicine. Eikenberry will see patients at the University Hospital clinic.
Waddell will see patients at the Wishard Memorial Hospital clinic. Both were residents in the IU medical school’s department
of ophthalmology.

Catherine A. Clements has joined the health and life sciences practice group at Baker & Daniels LLP.
Clements earned her law degree in 2009 from Indiana University in Bloomington. Before that, she helped develop clinical trials
at Eli Lilly and Co. and the Roudebush Veterans Affairs Medical Center in Indianapolis.

Lilly woes take notch out of debt rating

August 24, 2010

Even with debt levels at Eli Lilly and Co. at paltry lows, a string of bad news finally forced Standard & Poor’s
to lower
its rating on the company’s senior unsecured debt. But the New York-based agency said it believes the Indianapolis-based
drugmaker will eventually break its string of bad luck on developing new products.

Indiana, Indy stage small employment gains

August 20, 2010

Indiana’s unemployment rate increased by a sliver, to 10.2 percent, in July despite increases in jobs in many industries.

Pearl IRB first firm in state to pre-screen clinical drug trials

August 19, 2010

Two former Eli Lilly and Co. employees launched the firm that promises to attract more clinical trial business to the state.

Lilly gains panel’s backing to expand Cymbalta use

August 19, 2010

Outside advisers to the Food and Drug Administration voted 8-6 Thursday in favor of a broader use of Cymbalta on the basis
of studies in lower back pain and osteoarthritis of the knee.

Lilly wins temporary ban on sales of Strattera copies

August 19, 2010

The invalidation of Lilly’s Strattera patent opened the door for as many as 10 companies to sell generic versions of the drug,
which generated U.S. sales of $445.6 million last year as a treatment for attention deficit hyperactivity disorder.

Lilly Alzheimer’s drug prospect only the latest to fail

August 18, 2010

A dozen potential products designed to slow or stop clumps of protein from forming in the brain, a condition linked to the
disease since 1906, have failed in mid- to late-stage testing since 2003.

Lilly’s Cymbalta helps chronic pain in U.S. review

August 17, 2010

Approval for the millions of Americans with chronic back or knee pain may add more than $500 million, or 16 percent, to Cymbalta’s
annual sales.

Lilly halts development of Alzheimer’s drug

August 17, 2010

Studies showed that the treatment did not slow the disease's progression. It's just the latest setback for the pharmaceutical
giant, which lost a patent lawsuit over a major drug last week and faces an unprecedented number of patent expirations through
2014.

« Previous 1 … 166 167 168 169 170 … 221 Next »

Search Results

4,410 results for '\"eli lilly\"'

Articles

Lilly wins ban of generic Strattera pending appeal

CFO of the Year: Past recipients

After health reform, Lilly looking for more

Lilly wins further delay in sales of Strattera copies

Indiana universities nearly double research spending

Funeral company in 129th year keeps fresh perspective

Diabetes research pioneer Kirtley dies at 96

A half-century later, Indiana Landmarks returns to roots

People

Lilly woes take notch out of debt rating

Indiana, Indy stage small employment gains

Pearl IRB first firm in state to pre-screen clinical drug trials

Lilly gains panel’s backing to expand Cymbalta use

Lilly wins temporary ban on sales of Strattera copies

Lilly Alzheimer’s drug prospect only the latest to fail

Lilly’s Cymbalta helps chronic pain in U.S. review

Lilly halts development of Alzheimer’s drug

Eli Lilly loses patent lawsuit for Strattera

Lilly braces for plunge in profits

MORRIS: Give and volunteer to Live United